Nicotinamide in Hemodialysis Patients With Hyperphosphatemia

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 252 participants.

Also called NCT01200784

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 252 participants (enrolled count) (from the registry)
Sponsor
Medice Arzneimittel Pütter GmbH & Co KG (from the registry)
Registry
  • NCT NCT01200784
  • EudraCT 2009-015821-34
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01200784. Randomized; double masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2011-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Nicotinamide in Hemodialysis Patients With Hyperphosphatemia
Acronym
DONATO
Condition
Hemodialysis
Condition
Hyperphosphatemia
Intervention (Drug)
Nicotinamide
Lead sponsor
Medice Arzneimittel Pütter GmbH & Co KG (class: industry)

Record details

Record id
cardio:ct-nct01200784
Content hash
cee4cc3985f70738f0675a797e2ee4fe9fcdc6b1a0aa3f5e14a8e0425ada1daa